Physician profile
David M Eldringhoff
NPI 1275895641
$7,594.76
in general payments reported to CMS, 2019-2025
11 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,912 · 2021: $31.03 · 2022: $228 · 2023: $117 · 2024: $90.03 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.99 |
| Education | $103.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,134.71 | 2019 | |
| Sportstek Medical, INC | $1,598.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $388.41 | 2022-2025 | Persona, Mymobility Platform, Juggerknotless Soft Anchor |
| Smith+Nephew, INC. | $175.84 | 2019-2024 | Journey II |
| Horizon Therapeutics Plc | $88.49 | 2021-2022 | |
| Bioventus LLC | $68.92 | 2019-2022 | |
| Globus Medical, INC. | $43.21 | 2023 | Proximal Humerus Strut, Ankle Fracture System |
| Linvatec Corporation | $29.25 | 2025 | Allograft Tissue, Biobrace 23mm, Linvatec Arthroscopy |
| Stryker Corporation | $25.00 | 2025 | Alphavent |
| Depuy Synthes Sales INC. | $21.62 | 2023 | Monovisc, Orthovisc |
| Heron Therapeutics, INC. | $21.31 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Eldringhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.